tiprankstipranks
Trending News
More News >
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
Hong Kong Market
Advertisement

Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a market cap or net worth of HK$2.15B. The enterprise value is HK$745.26M.
Market CapHK$2.15B
Enterprise ValueHK$745.26M

Share Statistics

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,565,804
Owned by Insiders
Owned by Institutions

Financial Efficiency

Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.63%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-0.63%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee807.85K
Profits Per Employee-34.86K
Employee Count344
Asset Turnover0.23
Inventory Turnover0.56

Valuation Ratios

The current PE Ratio of Shanghai Heartcare Medical Technology Corp. Ltd. Class H is 46.1. Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s PEG ratio is 0.67.
PE Ratio46.1
PS Ratio2.80
PB Ratio0.73
Price to Fair Value0.73
Price to FCF-92.80
Price to Operating Cash Flow261.55
PEG Ratio0.67

Income Statement

In the last 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H had revenue of 277.90M and earned -13.62M in profits. Earnings per share was -0.36.
Revenue277.90M
Gross Profit181.72M
Operating Income-6.24M
Pretax Income-11.99M
Net Income-13.62M
EBITDA21.87M
Earnings Per Share (EPS)-0.36

Cash Flow

In the last 12 months, operating cash flow was 41.60M and capital expenditures -11.05M, giving a free cash flow of 30.56M billion.
Operating Cash Flow41.60M
Free Cash Flow30.56M
Free Cash Flow per Share0.97

Dividends & Yields

Shanghai Heartcare Medical Technology Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.30
52-Week Price Change159.86%
50-Day Moving Average60.24
200-Day Moving Average38.72
Relative Strength Index (RSI)35.65
Average Volume (3m)127.28K

Important Dates

Shanghai Heartcare Medical Technology Corp. Ltd. Class H upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date

Financial Position

Shanghai Heartcare Medical Technology Corp. Ltd. Class H as a current ratio of 12.42, with Debt / Equity ratio of 3.37%
Current Ratio12.42
Quick Ratio10.34
Debt to Market Cap0.00
Net Debt to EBITDA-25.89
Interest Coverage Ratio-3.57

Taxes

In the past 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has paid 1.63M in taxes.
Income Tax1.63M
Effective Tax Rate-0.14

Enterprise Valuation

Shanghai Heartcare Medical Technology Corp. Ltd. Class H EV to EBITDA ratio is 9.72, with an EV/FCF ratio of -25.32.
EV to Sales0.76
EV to EBITDA9.72
EV to Free Cash Flow-25.32
EV to Operating Cash Flow-65.69

Balance Sheet

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has HK$718.20M in cash and marketable securities with HK$35.75M in debt, giving a net cash position of HK$672.29M billion.
Cash & Marketable SecuritiesHK$718.20M
Total DebtHK$35.75M
Net CashHK$672.29M
Net Cash Per ShareHK$21.30
Tangible Book Value Per ShareHK$26.98

Margins

Gross margin is 65.39%, with operating margin of -2.24%, and net profit margin of -4.90%.
Gross Margin65.39%
Operating Margin-2.24%
Pretax Margin-4.32%
Net Profit Margin-4.90%
EBITDA Margin7.87%
EBIT Margin-3.69%

Analyst Forecast

The average price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is HK$61.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$61.00
Price Target Upside10.21% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast32.93%
EPS Growth Forecast

Scores

Smart Score7
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis